Effect of flavin compounds on glutathione reductase activity: in vivo and in vitro studies.
Increases or decreases of red cell glutathione reductase (GR) have been described in connection with many clinical abnormalities. We find that GR activity as measured in hemolysates represents only a portion of the available GR activity. The addition of small amounts of flavin adenine dinucleotide (FAD), but not of flavin mononucleotide or riboflavin, activates the GR of hemolysates. 1 muM FAD results in a maximal activation within 10 min; gradually increasing activation occurs at much lower, for example, 20 mmuM FAD concentrations. Once FAD has activated GR, dilution or dialysis does not reverse activation of the enzyme. Activation of GR by FAD can be inhibited by adenosine triphosphate (ATP), and to a lesser extent by adenosine diphosphate (ADP) and adenosine monophosphate (AMP), if these adenine nucleotides are added before the addition of FAD, but only to a slight extent if FAD is added before the adenine nucleotides. The addition of FAD to GR does not alter its electrophoretic mobility but produces intensification of the bands. The administration of 5 mg of riboflavin daily produces marked stimulation of red cell GR activity within only 2 days. After cessation of riboflavin administration, the GR activity again begins to fall. The degree of stimulation of GR activity by riboflavin is inversely correlated with the level of dietary riboflavin intake. The base line GR activity of normal individuals is directly correlated with the level of dietary riboflavin intake. The previously unexplained variations of glutathione reductase in health and disease must be reevaluated in light of the state of riboflavin nutrition and metabolism of the subject.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000293:Adolescent; D000328:Adult; D002648:Child; D004032:Diet; D004912:Erythrocytes / Q000201:enzymology*; D005260:Female; D005486:Flavin Mononucleotide / Q000494:pharmacology; D005182:Flavin-Adenine Dinucleotide / Q000097:blood / Q000494:pharmacology; D005980:Glutathione Reductase / Q000097:blood / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012256:Riboflavin / Q000378:metabolism* / Q000627:therapeutic use*
D000227:Adenine Nucleotides; D005182:Flavin-Adenine Dinucleotide; D005486:Flavin Mononucleotide; D000255:Adenosine Triphosphate; D005980:Glutathione Reductase; D012256:Riboflavin
Klin Wochenschr. 1965 Apr 15;43(8):413-26
5830956
Clin Chim Acta. 1966 Mar;13(3):269-72
5943819
Blood. 1966 Oct;28(4):553-62
5923607
Science. 1967 Feb 10;155(3763):712-3
6017801
Schweiz Med Wochenschr. 1966 Mar 19;96(11):355-7
5987762
Scand J Clin Lab Invest Suppl. 1967;96:1-67
6074170
Nature. 1968 Jan 20;217(5125):256-8
4384274
Biochim Biophys Acta. 1968 Mar 25;151(3):686-8
4171462
Am J Clin Nutr. 1968 May;21(5):502-7
5649471
Dtsch Med Wochenschr. 1968 May 24;93(21):1063-6
5655845
Klin Wochenschr. 1967 Aug 15;45(16):824-6
5592449
Ned Tijdschr Geneeskd. 1968 May 25;112(21):1008-9
5669614
Humangenetik. 1968;6(2):163-70
5704435
Pharmacol Rev. 1969 Mar;21(1):73-103
4887725
Experientia. 1968 Nov 15;24(11):1122
5721130
J Pathol Bacteriol. 1953 Apr;65(2):559-64
13062056
J Lab Clin Med. 1958 Jul;52(1):109-17
13549855
J Biol Chem. 1963 Jan;238:464-8
14017468
J Biol Chem. 1963 Dec;238:3928-33
14086726
Blood. 1965 Apr;25:432-42
14284333
J Clin Invest. 1959 Sep;38:1605-16
13800266